Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

The immunosuppressive activity of heat shock protein 70.

Stocki P, Dickinson AM.

Autoimmune Dis. 2012;2012:617213. doi: 10.1155/2012/617213. Epub 2012 Dec 17.

2.

Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.

Marincek BC, Kühnle MC, Srokowski C, Schild H, Hämmerling G, Momburg F.

Mol Immunol. 2008 Nov;46(1):181-91. doi: 10.1016/j.molimm.2008.07.039. Epub 2008 Sep 18.

PMID:
18804283
4.

Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling.

Bendz H, Ruhland SC, Pandya MJ, Hainzl O, Riegelsberger S, Braüchle C, Mayer MP, Buchner J, Issels RD, Noessner E.

J Biol Chem. 2007 Oct 26;282(43):31688-702. Epub 2007 Aug 7.

5.

Heat shock protein 70: role in antigen presentation and immune stimulation.

Milani V, Noessner E, Ghose S, Kuppner M, Ahrens B, Scharner A, Gastpar R, Issels RD.

Int J Hyperthermia. 2002 Nov-Dec;18(6):563-75. Review.

PMID:
12537755
6.

Immunostimulatory functions of membrane-bound and exported heat shock protein 70.

Radons J, Multhoff G.

Exerc Immunol Rev. 2005;11:17-33. Review.

7.
8.

HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family.

Nossner E, Goldberg JE, Naftzger C, Lyu SC, Clayberger C, Krensky AM.

J Exp Med. 1996 Feb 1;183(2):339-48.

9.

HSP110 induces "danger signals" upon interaction with antigen presenting cells and mouse mammary carcinoma.

Manjili MH, Park J, Facciponte JG, Subjeck JR.

Immunobiology. 2005;210(5):295-303.

PMID:
16164037
10.

Interaction of human heat shock protein 70 with tumor-associated peptides.

Pandya MJ, Bendz H, Manzenrieder F, Noessner E, Kessler H, Buchner J, Issels RD.

Biol Chem. 2009 Apr;390(4):305-12. doi: 10.1515/BC.2009.038.

PMID:
19199830
11.

Enhanced immunity against hepatoma induced by dendritic cells pulsed with Hsp70-H22 peptide complexes and CD40L.

Gao J, Luo SM, Peng ML, Deng T.

J Cancer Res Clin Oncol. 2012 Jun;138(6):917-26. doi: 10.1007/s00432-012-1166-6. Epub 2012 Feb 11.

PMID:
22327301
12.

Human recombinant heat shock protein 70 affects the maturation pathways of dendritic cells in vitro and has an in vivo adjuvant activity.

Valentinis B, Capobianco A, Esposito F, Bianchi A, Rovere-Querini P, Manfredi AA, Traversari C.

J Leukoc Biol. 2008 Jul;84(1):199-206. doi: 10.1189/jlb.0807548. Epub 2008 May 2.

PMID:
18456818
13.

Distinct binding sites for the ATPase and substrate-binding domain of human Hsp70 on the cell surface of antigen presenting cells.

Zitzler S, Hellwig A, Hartl FU, Wieland F, Diestelkötter-Bachert P.

Mol Immunol. 2008 Sep;45(15):3974-83. doi: 10.1016/j.molimm.2008.06.022. Epub 2008 Jul 26.

PMID:
18657319
14.

Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells.

Noessner E, Gastpar R, Milani V, Brandl A, Hutzler PJ, Kuppner MC, Roos M, Kremmer E, Asea A, Calderwood SK, Issels RD.

J Immunol. 2002 Nov 15;169(10):5424-32.

15.
16.

Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum.

Behr C, Sarthou JL, Rogier C, Trape JF, Dat MH, Michel JC, Aribot G, Dieye A, Claverie JM, Druihle P, et al.

J Immunol. 1992 Nov 15;149(10):3321-30.

PMID:
1431109
17.

Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70.

Moroi Y, Mayhew M, Trcka J, Hoe MH, Takechi Y, Hartl FU, Rothman JE, Houghton AN.

Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3485-90.

18.

Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine.

Ren W, Strube R, Zhang X, Chen SY, Huang XF.

Cancer Res. 2004 Sep 15;64(18):6645-51.

19.

Heat shock protein 70 upregulation is related to HLA-DR expression in bronchial asthma. Effects of inhaled glucocorticoids.

Bertorelli G, Bocchino V, Zhuo X, Chetta A, Del Donno M, Foresi A, Testi R, Olivieri D.

Clin Exp Allergy. 1998 May;28(5):551-60.

PMID:
9645591
20.

Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70.

Koide T, Iinuma H, Fukushima R.

Oncol Rep. 2009 Mar;21(3):737-46.

PMID:
19212634

Supplemental Content

Support Center